Antares Pharma, Inc. (ATRS)

Cash & Short-Term Investments

$62.21M

Quarterly · Period ending: · USD

ATRS logo

ATRS Cash & Short-Term Investments

Latest reported$62.21M
ATRS Quarterly Cash & Short-Term Investments ($2.20M → $62.21M)
High-resolution chart · PNG

ATRS cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
6,300,000
11,039,517
1,300,000
2,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.